(Q38514109)

3 September 2017

Genetic variations of the dihydrofolate reductase gene of Plasmodium vivax in Mandalay Division, Myanmar (English)

1 reference

3 September 2017

0 references

1 reference

1

Byoung-Kuk Na

1 reference

3 September 2017

Hyeong-Woo Lee

2

1 reference

3 September 2017

Sung-Ung Moon

3

1 reference

3 September 2017

Tae-Suk In

4

1 reference

3 September 2017

Khin Lin

5

1 reference

3 September 2017

Maung Maung

6

1 reference

3 September 2017

Gyung-Tae Chung

7

1 reference

3 September 2017

Jong-Koo Lee

8

1 reference

3 September 2017

Tong-Soo Kim

9

1 reference

3 September 2017

Yoon Kong

10

1 reference

3 September 2017

28 May 2005

1 reference

3 September 2017

Parasitology Research

1 reference

3 September 2017

96

1 reference

3 September 2017

5

1 reference

3 September 2017

321-325

1 reference

https://scigraph.springernature.com/pub.10.1007/s00436-005-1364-0

3 September 2017

0 references

cites work

Hospital cost containment in the 1980s. Hard lessons learned and prospects for the 1990s

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00436-005-1364-0

Chloroquine-resistant Plasmodium vivax malaria in Peru.

21 January 2018

1 reference

12 December 2020

Mutational analysis of Plasmodium falciparum dihydrofolate reductase: the role of aspartate 54 and phenylalanine 223 on catalytic activity and antifolate binding.

1 reference

12 December 2020

Genetic variation of the dihydrofolate reductase gene in Plasmodium vivax in Snoul, northeastern Cambodia

1 reference

12 December 2020

Sequence variations in the Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene and their relationship with pyrimethamine resistance

1 reference

12 December 2020

Molecular characterization of dihydrofolate reductase in relation to antifolate resistance in Plasmodium vivax

1 reference

12 December 2020

A single-step, PCR-based method for the detection and differentiation of Plasmodium vivax and P. falciparum

1 reference

12 December 2020

Plasmodium vivax synonymous substitution frequencies, evolution and population structure deduced from diversity in AMA 1 and MSP 1 genes

1 reference

12 December 2020

The neglected burden of Plasmodium vivax malaria

1 reference

12 December 2020

Validation of a simplified method for using molecular markers to predict sulfadoxine-pyrimethamine treatment failure in African children with falciparum malaria.

1 reference

12 December 2020

Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria

1 reference

12 December 2020

Chloroquine-resistant Plasmodium vivax in transmigration settlements of West Kalimantan, Indonesia.

1 reference

12 December 2020

Assessment of the pharmacodynamic properties of antimalarial drugs in vivo

1 reference

12 December 2020

Therapeutic responses to different antimalarial drugs in vivax malaria

1 reference

12 December 2020

Dihydrofolate reductase mutations in Plasmodium vivax from Indonesia and therapeutic response to sulfadoxine plus pyrimethamine

1 reference

12 December 2020

Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: geographical and clinical correlates

1 reference

12 December 2020

Novel point mutations in the dihydrofolate reductase gene of Plasmodium vivax: evidence for sequential selection by drug pressure

1 reference

12 December 2020

Evaluation of cysteine proteases of Plasmodium vivax as antimalarial drug targets: sequence analysis and sensitivity to cysteine protease inhibitors

1 reference

12 December 2020

Chloroquine-resistant Plasmodium vivax from Indonesia

1 reference

12 December 2020

In vitro susceptibility of Plasmodium falciparum isolates from Myanmar to antimalarial drugs

1 reference

12 December 2020

Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar

1 reference

12 December 2020

Emergence of chloroquine-resistant Plasmodium vivax in Myanmar (Burma).

1 reference

12 December 2020

Plasmodium falciparum: sensitivity in vivo to chloroquine, pyrimethamine/sulfadoxine and mefloquine in western Myanmar

1 reference

12 December 2020

Plasmodium falciparum: correlation of in vivo resistance to chloroquine and antifolates with genetic polymorphisms in isolates from the south of Lao PDR.

1 reference

12 December 2020

Treatment of primaquine-resistant Plasmodium vivax malaria

1 reference

12 December 2020

10.1007/S00436-005-1364-0

Identifiers

DOI

1 reference

Dimensions Publication ID

3 September 2017

0 references

1 reference